Promoter Regions, Genetic
"Promoter Regions, Genetic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes.
| Descriptor ID |
D011401
|
| MeSH Number(s) |
G02.111.570.080.689.675 G05.360.080.689.675 G05.360.340.024.340.137.750.680
|
| Concept/Terms |
Promoter Regions, Genetic- Promoter Regions, Genetic
- Genetic Promoter Region
- Genetic Promoter Regions
- Promoter Region, Genetic
- Region, Genetic Promoter
- Regions, Genetic Promoter
- Promoter Regions
- Promoter Region
- Region, Promoter
- Regions, Promoter
- Promotor Regions
- Promotor Region
- Region, Promotor
- Regions, Promotor
rRNA Promoter- rRNA Promoter
- Promoter, rRNA
- Promoters, rRNA
- rRNA Promoters
Promoter, Genetic- Promoter, Genetic
- Genetic Promoter
- Genetic Promoters
- Promoters, Genetic
- Promotor, Genetic
- Genetic Promotor
- Genetic Promotors
- Promotors, Genetic
Pseudopromoter, Genetic- Pseudopromoter, Genetic
- Genetic Pseudopromoter
- Genetic Pseudopromoters
- Pseudopromoters, Genetic
|
Below are MeSH descriptors whose meaning is more general than "Promoter Regions, Genetic".
Below are MeSH descriptors whose meaning is more specific than "Promoter Regions, Genetic".
This graph shows the total number of publications written about "Promoter Regions, Genetic" by people in this website by year, and whether "Promoter Regions, Genetic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 3 | 5 | 8 |
| 1996 | 4 | 10 | 14 |
| 1997 | 4 | 12 | 16 |
| 1998 | 2 | 11 | 13 |
| 1999 | 2 | 5 | 7 |
| 2000 | 5 | 7 | 12 |
| 2001 | 5 | 9 | 14 |
| 2002 | 3 | 12 | 15 |
| 2003 | 8 | 17 | 25 |
| 2004 | 6 | 21 | 27 |
| 2005 | 4 | 14 | 18 |
| 2006 | 2 | 25 | 27 |
| 2007 | 3 | 20 | 23 |
| 2008 | 8 | 23 | 31 |
| 2009 | 1 | 18 | 19 |
| 2010 | 6 | 13 | 19 |
| 2011 | 2 | 8 | 10 |
| 2012 | 2 | 14 | 16 |
| 2013 | 3 | 15 | 18 |
| 2014 | 4 | 12 | 16 |
| 2015 | 8 | 10 | 18 |
| 2016 | 2 | 11 | 13 |
| 2017 | 0 | 9 | 9 |
| 2018 | 0 | 6 | 6 |
| 2019 | 0 | 10 | 10 |
| 2020 | 0 | 5 | 5 |
| 2021 | 0 | 6 | 6 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Promoter Regions, Genetic" by people in Profiles.
-
Dysregulated TP53 Among PTSD Patients Leads to Downregulation of miRNA let-7a and Promotes an Inflammatory Th17 Phenotype. Front Immunol. 2021; 12:815840.
-
The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer. Nat Commun. 2021 12 21; 12(1):7349.
-
Acinetobacter baumannii Regulates Its Stress Responses via the BfmRS Two-Component Regulatory System. J Bacteriol. 2022 02 15; 204(2):e0049421.
-
Nucleic Acid-Sensing and Interferon-Inducible Pathways Show Differential Methylation in MZ Twins Discordant for Lupus and Overexpression in Independent Lupus Samples: Implications for Pathogenic Mechanism and Drug Targeting. Genes (Basel). 2021 11 26; 12(12).
-
Pediatric Gliosarcoma With and Without Neurofibromatosis Type 1: A Whole-exome Comparison of 2 Patients. J Pediatr Hematol Oncol. 2021 11 01; 43(8):e1201-e1204.
-
Live cell dynamics of the NF-Y transcription factor. Sci Rep. 2021 05 26; 11(1):10992.
-
Differential DNA Methylation Landscape in Skin Fibroblasts from African Americans with Systemic Sclerosis. Genes (Basel). 2021 01 20; 12(2).
-
Expression of GM-CSF Is Regulated by Fli-1 Transcription Factor, a Potential Drug Target. J Immunol. 2021 01 01; 206(1):59-66.
-
Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma. J Clin Oncol. 2020 10 10; 38(29):3407-3417.
-
ATF3 Coordinates Antitumor Synergy between Epigenetic Drugs and Protein Disulfide Isomerase Inhibitors. Cancer Res. 2020 08 15; 80(16):3279-3291.